Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria
Clinical trial NCT03520036 · COMPLETED
Trial details
- NCT number
- NCT03520036
- Sponsor
- Tanabe Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-05
- Primary completion
- 2019-09-28
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.